We are live on ! Find out more
TCA

Transcend Capital Advisors Portfolio holdings

AUM $1.25B
1-Year Est. Return 17.69%
This Fund
S&P 500
This Quarter Est. Return
-14.18%
1 Year Est. Return
+17.69%
3 Year Est. Return
+61.21%
5 Year Est. Return
+70.44%
10 Year Est. Return
AUM
$334M
AUM Growth
-$37.8M
Cap. Flow
+$28M
Cap. Flow %
8.41%
Top 10 Hldgs %
30.35%
Holding
253
New
42
Increased
80
Reduced
77
Closed
43

Sector Composition

Rank Sector Weight
1 Healthcare 18.03%
2 Technology 15.97%
3 Financials 12.2%
4 Consumer Staples 6.02%
5 Communication Services 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
151
Lockheed Martin
LMT
$131B
$439K 0.13%
1,254
-93
-7% -$36.6K
TJX icon
152
TJX Companies
TJX
$179B
$438K 0.13%
9,154
-159
-2% -$9.15K
QUS icon
153
State Street SPDR MSCI USA StrategicFactors ETF
QUS
$1.52B
$432K 0.13%
5,650
-1,702
-23% -$153K
IAT icon
154
iShares US Regional Banks ETF
IAT
$673M
$419K 0.13%
14,500
VHT icon
155
Vanguard Health Care ETF
VHT
$18.5B
$415K 0.12%
2,500
-923
-27% -$169K
NFLX icon
156
Netflix
NFLX
$307B
$409K 0.12%
10,900
+430
+4% +$15.2K
UBER icon
157
Uber
UBER
$145B
$398K 0.12%
+14,240
New +$469K
BAX icon
158
Baxter International
BAX
$12.8B
$390K 0.12%
4,805
-7
-0.1% -$604
CL icon
159
Colgate-Palmolive
CL
$74.8B
$381K 0.11%
+5,678
New +$400K
CMCSA icon
160
Comcast
CMCSA
$87.3B
$367K 0.11%
10,432
-12,614
-55% -$532K
TOTL icon
161
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.1B
$355K 0.11%
7,410
-847
-10% -$41.6K
GSK icon
162
GSK
GSK
$107B
$352K 0.11%
7,438
-236
-3% -$12.6K
DSL
163
DoubleLine Income Solutions Fund
DSL
$1.22B
$351K 0.11%
26,335
-1,632
-6% -$30K
IBB icon
164
iShares Biotechnology ETF
IBB
$9.45B
$351K 0.11%
+3,258
New +$375K
AMLP icon
165
Alerian MLP ETF
AMLP
$12.9B
$349K 0.1%
20,297
+387
+2% +$13.1K
PGC icon
166
Peapack-Gladstone Financial
PGC
$815M
$348K 0.1%
19,391
VFH icon
167
Vanguard Financials ETF
VFH
$13.4B
$347K 0.1%
6,842
-3,290
-32% -$224K
SPYV icon
168
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.2B
$342K 0.1%
13,253
-2,720
-17% -$86.9K
SYK icon
169
Stryker
SYK
$135B
$341K 0.1%
2,050
+26
+1% +$5.08K
MPT
170
Medical Properties Trust
MPT
$2.84B
$329K 0.1%
+19,049
New +$398K
WMT icon
171
Walmart Inc
WMT
$909B
$327K 0.1%
8,637
-660
-7% -$25.4K
AGG icon
172
iShares Core US Aggregate Bond ETF
AGG
$138B
$290K 0.09%
2,510
-100
-4% -$11.4K
ALL icon
173
Allstate
ALL
$70.6B
$286K 0.09%
3,131
-86
-3% -$9.35K
IBM icon
174
IBM
IBM
$213B
$275K 0.08%
2,596
+908
+54% +$115K
SPYM
175
State Street SPDR Portfolio S&P 500 ETF
SPYM
$157B
$271K 0.08%
8,963
+3,011
+51% +$108K

Similar funds

Transcend Capital Advisors's Q1 2020 Portfolio in Review

As of Q1 2020, Transcend Capital Advisors held 253 positions worth $334M, down 10% from $371M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Transcend Capital Advisors deployed $28M of net new capital in Q1 2020, opening 42 new positions and adding to 80 existing holdings. Its largest new stake was Alphabet (Google) Class A: 80,480 shares worth $4.68M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR Portfolio Developed World ex-US ETF, an estimated $4.56M trimmed.

  • Transcend Capital Advisors's largest Q1 2020 buy was Alphabet (Google) Class A: 80,480 shares worth $4.68M.
  • Transcend Capital Advisors added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q1 2020, an estimated $7.6M increase.
  • Transcend Capital Advisors's biggest Q1 2020 reduction was State Street SPDR Portfolio Developed World ex-US ETF, cutting an estimated $4.56M.
  • Transcend Capital Advisors fully exited Royal Dutch Shell PLC ADS Class B in Q1 2020, selling an estimated $3.65M.
  • Transcend Capital Advisors's ten largest holdings make up 30% of its $334M portfolio in Q1 2020.
  • Transcend Capital Advisors opened 42 new positions and closed 43 in Q1 2020.
  • Transcend Capital Advisors's portfolio value fell 10% quarter-over-quarter to $334M.

Based on Transcend Capital Advisors's 13F filing for Q1 2020, filed 8 May 2020.